GEN.ORPH

genorph-logo

Gen.Orph focuses its efforts on providing patients and the international medical community with efficient and affordable orphan drugs for the treatment of certain rare diseases, drugs that have been abandoned by the industry but retain attractive medical and economic potential, as well as innovative and / or classic drugs for frequent diseases

#Website #More

GEN.ORPH

Industry:
Health Care Medical

Address:
Saint-cloud, Ile-de-France, France

Country:
France

Website Url:
http://www.gen-orph.com

Status:
Active

Contact:
+0664108202

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Amazon AJAX Libraries API OpenResty


Official Site Inspections

http://www.gen-orph.com

  • Host name: ec2-54-183-102-22.us-west-1.compute.amazonaws.com
  • IP address: 54.183.102.22
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Gen.Orph"

Genorph - La solution aux maladies orphelines

Gen.Orph concentre ses efforts sur la mise à disposition des patients et du corps médical international de médicaments orphelins utiles et abordables en vue du traitement de certaines maladies rares, de médicaments classiques, โ€ฆSee details»

Gen.Orph - Crunchbase Company Profile & Funding

Gen.Orph focuses its efforts on providing patients and the international medical community with efficient and affordable orphan drugs for the treatment of โ€ฆSee details»

Gen.Orph Company Profile 2024: Valuation, Funding & Investors

Gen.Orph General Information Description. Developer of generic orphan drugs designed to treat rare diseases in children. The company's drugs offer patients and medical teams worldwide โ€ฆSee details»

Orphanet: GEN.ORPH

GEN.ORPH. institutions.detail.person.activities. Marketing authorisation holder Gen.Orph Gen.Orph 100 Rue Louis Blanc, TSA / Batiment Copenhague 60160 MONTATAIRE FRANCE โ€ฆSee details»

GEN ORPH - Crédit Mutuel Innovation

Gen Orph optimises access for healthcare professionals and patients to effective and affordable medicines to treat certain rare diseases. Discover the website of the company. 3 employees; Marketing of 5 medicines against rare diseases ...See details»

Gen.Orph - Overview, News & Similar companies | ZoomInfo.com

View Gen.Orph (www.gen-orph.com) location in France , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

GEN.ORPH - Dun & Bradstreet

Gen.orph. d&b business directory home / business directory / wholesale trade / merchant wholesalers, nondurable goods / drugs and druggists' sundries merchant wholesalers / france โ€ฆSee details»

Gen.Orph - Crunchbase

Gen.Orph focuses its efforts on providing patients and the international medical community.See details»

GEN.ORPH Company Profile | , Norway - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for GEN.ORPH of . Get the latest business insights from Dun & Bradstreet.See details»

Gen.Orph - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Gen.Orph focuses its efforts on providing patients and the international medical community.See details»

Abacus Medicine Pharma Services and Gen.Orph Sign Partnership โ€ฆ

Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in โ€ฆSee details»

GEN ORPH - creditmutuel-equity.eu

Gen Orph optimises access for healthcare professionals and patients to effective and affordable medicines to treat certain rare diseases. Discover the website of the company. 3 employees; โ€ฆSee details»

EU Risk Management Plan for Ibuprofen Gen.Orph 5 mg/mL โ€ฆ

This is a summary of the risk management plan (RMP) for Ibuprofen Gen.Orph 5 mg/mL solution for injection. The RMP details important risks of buprofIen Gen.Orph 5 mg/mL solution for โ€ฆSee details»

Ibuprofen Gen.Orph | European Medicines Agency (EMA)

Ibuprofen Gen.Orph is a medicine used to treat โ€˜patent ductus arteriosusโ€™ in newborn premature babies who were born six or more weeks too early (less than 34 weeks gestational age). โ€ฆSee details»

Gen.Orph Company Profile | Unknown, Unknown, Belgium

Find company research, competitor information, contact details & financial data for Gen.Orph of Unknown, Unknown. Get the latest business insights from Dun & Bradstreet.See details»

Ibuprofen Gen.Orph, INN-Ibuprofen - ema.europa.eu

Treatment with Ibuprofen Gen.Orph should only be carried out in a neonatal intensive care unit under the supervision of an experienced neonatologist. Posology A course of therapy is โ€ฆSee details»

Gen.orph Company Profile | , Norway | Competitors, Financials ...

Find company research, competitor information, contact details & financial data for Gen.orph of . Get the latest business insights from Dun & Bradstreet.See details»

Open Orphan - Crunchbase Company Profile & Funding

Stock Symbol LSE:ORPH ; Company Type For Profit; Contact Email [email protected]; Phone Number +353 (01) 6440007; Open Orphan Open Orphan is a rapidly growing niche โ€ฆSee details»

Ibuprofen Gen.Orph - news.pda.org

Overview Ibuprofen Gen.Orph is a medicine used to treat โ€˜patent ductus arteriosusโ€™ in newborn premature babies who were born six or more weeks too ...See details»

Miglustat Gen.Orph 100 mg hard capsules - medicines

Miglustat Gen.Orph may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable (see sections 4.4 and 5.1). Miglustat Gen.Orph is indicated for the โ€ฆSee details»